Home > Financial Ratios > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Core EBITDA Margin

    Back to All Ratios
KILITCH DRUGS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 15.7212.709.197.74-0.01

What is the latest Core EBITDA Margin ratio of KILITCH DRUGS (INDIA) ?

The latest Core EBITDA Margin ratio of KILITCH DRUGS (INDIA) is 15.72 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202415.72
Mar202312.70
Mar20229.19
Mar20217.74
Mar2020-0.01

How is Core EBITDA Margin of KILITCH DRUGS (INDIA) Trending?

Years Core EBITDA Margin % Change
Mar2024 15.72
23.78
Mar2023 12.7
38.19
Mar2022 9.19
18.73
Mar2021 7.74
Positive
Mar2020 -0.01 -

Other Financial Ratios of KILITCH DRUGS (INDIA)


Compare Core EBITDA Margin ratio of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹558.8 Cr 0.6% 10.2% -4.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,136.0 Cr 6% 4% 9.9% Stock Analytics
DIVIS LABORATORIES ₹149,680.0 Cr 4.7% 0.3% 52.4% Stock Analytics
CIPLA ₹122,394.0 Cr 7% 3.7% 7.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,159.0 Cr 4.1% 6.4% 25% Stock Analytics
DR REDDYS LABORATORIES ₹97,105.6 Cr 6.3% 5% -4.7% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

0.6%

10.2%

-4.6%

SENSEX

5.8%

6.1%

4.7%


You may also like the below Video Courses